CRL Logo

Charles River Laboratories International, Inc. (CRL) 

NYSE
Market Cap
$10.27B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
443 of 966
Rank in Industry
23 of 53

Largest Insider Buys in Sector

CRL Stock Price History Chart

CRL Stock Performance

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Insider Activity of Charles River Laboratories International, Inc.

Over the last 12 months, insiders at Charles River Laboratories International, Inc. have bought $0 and sold $15.66M worth of Charles River Laboratories International, Inc. stock.

On average, over the past 5 years, insiders at Charles River Laboratories International, Inc. have bought $1.28M and sold $33.91M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,322 shares for transaction amount of $248,298 was made by Girshick Birgit (Corporate Executive VP & COO) on 2023‑11‑20.

List of Insider Buy and Sell Transactions, Charles River Laboratories International, Inc.

2024-11-07Saledirector
7,621
0.0151%
$216.17$1.65M-5.23%
2024-08-08SaleEVP, Corp Strategy & Develop
1,780
0.0034%
$199.36$354,861-2.46%
2024-08-01SaleChairman, President and CEO
25,000
0.05%
$250.00$6.25M-18.56%
2024-05-15Saledirector
332
0.0007%
$235.62$78,225-12.39%
2024-05-10SaleEVP, Corp Strategy & Develop
1,304
0.0025%
$226.97$295,969-10.40%
2024-03-08SaleCSVP&Chief Accounting Officer
808
0.0016%
$267.52$216,156-20.77%
2024-03-04SaleCSVP&Chief Accounting Officer
2,750
0.0054%
$261.05$717,890-17.68%
2024-02-29SaleEVP & Chief People Officer
5,000
0.0097%
$253.70$1.27M-15.80%
2024-02-29SaleCEVP, Disc & Safety Assessment
3,786
0.0073%
$253.45$959,545-15.80%
2024-02-22SaleCorporate Executive VP & CCO
4,050
0.0079%
$248.50$1.01M-13.04%
2024-02-15SaleEVP, Corp Strategy & Develop
838
0.0016%
$238.93$200,223-12.23%
2024-02-15SaleCEVP, Disc & Safety Assessment
5,882
0.0113%
$241.20$1.42M-12.23%
2023-12-14SaleEVP & Chief People Officer
5,526
0.0106%
$225.00$1.24M-4.05%
2023-11-30SaleEVP, Corp Strategy & Develop
1,850
0.0036%
$197.73$365,801+11.10%
2023-11-20PurchaseCorporate Executive VP & COO
1,322
0.0025%
$187.82$248,298+14.37%
2023-11-14PurchaseChairman, President and CEO
5,620
0.0109%
$178.05$1M+21.69%
2023-11-09SaleEVP, Corp Strategy & Develop
9,128
0.0182%
$173.48$1.58M+28.79%
2023-08-24Purchasedirector
1,000
0.0019%
$198.79$198,786+8.50%
2023-08-10SaleEVP, Corp Strategy & Develop
700
0.0014%
$216.52$151,564-1.30%
2023-08-10SaleCSVP&Chief Accounting Officer
1,471
0.0029%
$216.54$318,530-1.30%

Insider Historical Profitability

5.8%
FOSTER JAMES CChairman, President and CEO
188251
0.3681%
$200.89684+4.13%
Barbo William DCorporate Executive VP & CCO
22879
0.0447%
$200.89013
LaPlume Joseph WEVP, Corp Strategy & Develop
22521
0.044%
$200.89020
Creamer Victoria LEVP & Chief People Officer
13550
0.0265%
$200.8903
Knell Michael GunnarCSVP&Chief Accounting Officer
7825
0.0153%
$200.8908
MASSARO GEORGEdirector
5855
0.0114%
$200.89032
Parisotto Shannon MCEVP, Disc & Safety Assessment
4792
0.0094%
$200.8904
WALLMAN RICHARD Fdirector
0
0%
$200.89413+7.27%
CAWTHORN ROBERTdirector
286700
0.5607%
$200.8902
JOHST DAVID PCorporate Executive VP
212854
0.4162%
$200.89028
NIMMO WALTER Sdirector
149447
0.2923%
$200.8905
ACKERMAN THOMAS F
111698
0.2184%
$200.89041
RENAUD REAL HCorp. Executive VP
63586
0.1243%
$200.89012
REESE C RICHARDdirector
56457
0.1104%
$200.8904
Girshick BirgitCorporate Executive VP & COO
44449
0.0869%
$200.89113
CHUBB STEPHEN Ddirector
40529
0.0793%
$200.89040
SHAUGHNESSY DENNIS RSr. VP Corporate Development
37761
0.0738%
$200.8903
BERTOLINI ROBERT Jdirector
29134
0.057%
$200.8905
MILNE GEORGE M JRdirector
28417
0.0556%
$200.89010
Smith David RossCorporate Executive VP & CFO
27064
0.0529%
$200.89028
WALTRIP WILLIAMdirector
21830
0.0427%
$200.8905
Molho DavidePresident & COO
17155
0.0335%
$200.89020
BATHGATE BRIANCorporate Vice President
16134
0.0316%
$200.8908
BERTHOUX CHRISTOPHERCorp Sr VP
15047
0.0294%
$200.8907
THIER SAMUEL O MDdirector
14190
0.0277%
$200.89017
GELLER JORGCorporate Executive VP
14094
0.0276%
$200.89026
URQUHART JOHNdirector
11738
0.023%
$200.8902
ELLIOTT DAVID JOfficer
11750
0.023%
$200.8901
GILLETT NANCYCorporate Executive VP
11034
0.0216%
$200.89141+0.49%
Ho John CSenior Vice President
8950
0.0175%
$200.8910+15.04%
Kochevar Deborah Turnerdirector
6096
0.0119%
$200.89010
Crowley John JSVP, Chief Accounting Officer
5883
0.0115%
$200.8903
ROGERS DOUGLAS Edirector
5349
0.0105%
$200.8901
ANKCORN MICHAEL FCorp. Sr. VP
0
0%
$200.8903
MCEWAN ALASTAIR STUARTCorporate VP
0
0%
$200.8903

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.64B11.746.05M+1.11%+$17.93M0.03
BlackRock$1.4B10.045.17M+0.2%+$2.82M0.03
State Street$567.4M4.072.09M+1.67%+$9.3M0.02
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$508.74M3.651.88M+7.09%+$33.7M1.18
ClearBridge Investments$409.98M2.941.51M+3.07%+$12.21M0.33
T. Rowe Price$358.32M2.571.32M-8.37%-$32.71M0.04
Geode Capital Management$320.48M2.31.19M+3.48%+$10.77M0.03
Meritage Group LP$320.34M2.31.18M+2.33%+$7.29M7.55
Allspring Global Investments$303.14M2.171.12M-3.99%-$12.6M0.48
Ariel Investments$252.74M1.81932,807-11.22%-$31.94M2.49
Mackenzie Financial Corp$252.47M1.81931,797+1.52%+$3.78M0.34
EARNEST Partners$242.16M1.74893,761+0.49%+$1.19M1.11
Invesco$241.83M1.73892,524-5.88%-$15.12M0.05
Bank of America$240.92M1.73889,170+20.79%+$41.47M0.02
Southpoint Capital Advisors Lp$189.66M1.36700,000-30%-$81.28M3.75
Marshall Wace$179.6M1.29662,849New+$179.6M0.18
Franklin Templeton Investments$176.61M1.27651,805-14.57%-$30.13M0.05
SEI Investments Company$155.89M1.12575,349+1.26%+$1.94M0.23
Wells Fargo$154.28M1.11569,415+4.38%+$6.47M0.04
Thrivent Financial For Lutherans$153.32M1.1565,864+27.79%+$33.34M0.32
Montrusco Bolton Investments Inc$132.7M0.95489,751-32.18%-$62.95M1.42
Dimensional Fund Advisors$126.64M0.91467,393-3.02%-$3.94M0.03
Fidelity Investments$125.93M0.9464,765+22.54%+$23.16M0.01
Victory Capital Management Inc$124.59M0.89459,818-1.66%-$2.1M0.13
Northern Trust$124.43M0.89459,251-4.4%-$5.73M0.02
Congress Asset Management Co Ma$122.85M0.88453,392-2.55%-$3.22M0.88
Charles Schwab$121.6M0.87448,809-12.55%-$17.45M0.03
Morgan Stanley$117.88M0.85435,059-7.85%-$10.04M0.01
Fil Ltd$107.58M0.77397,045-40.08%-$71.97M0.11
BNY Mellon$104.05M0.75384,023-3.17%-$3.41M0.02
William Blair Investment Management$98.79M0.71364,614-1.62%-$1.62M0.26
JPMorgan Chase$96.03M0.69354,428+55.8%+$34.39M0.01
Luther King Capital Management$95.16M0.68351,205-4.26%-$4.23M0.43
Legal & General$88.43M0.63326,362-1.61%-$1.44M0.02
Van Berkom Associates Inc$84.39M0.61311,466-2.18%-$1.88M2.4
Envestnet Asset Management Inc$83.36M0.6307,663+14.56%+$10.59M0.03
Riverbridge Partners$82.31M0.59303,778+1.03%+$836,692.961.01
Ameriprise Financial$76.61M0.55282,736+1,098.8%+$70.22M0.02
PRIMECAP Management Co$74.22M0.53273,9300%+$00.05
Neuberger Berman$72.28M0.52266,823+3.57%+$2.49M0.06
Jackson Square LLC$68.09M0.49251,308-28.09%-$26.6M2.93
Raymond James Associates$67.29M0.48248,348+1.91%+$1.26M0.05
Epoch Investment Partners Inc$67.06M0.48247,501+2,733.44%+$64.69M0.3
Woodley Farra Manion Portfolio Management$65.88M0.47243,160+129.31%+$37.15M3.63
Bellevue Group$62.24M0.45229,697+5.48%+$3.24M0.95
Ubs Asset Management Americas Inc$59.79M0.43220,686+0.34%+$201,044.900.02
Citigroup$54.9M0.39202,617+11.51%+$5.67M0.04
Voya Investment Management LLC$54.39M0.39200,730-0.04%-$19,237.450.06
Boston Trust Walden Corp$52.82M0.38194,939-1.23%-$655,699.000.38
Fisher Asset Management Llc$50.03M0.36184,655-0.95%-$479,852.730.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.